Qinghai Spring Medicinal Resources Technology Co.,ltd. Class ASSE: 600381

Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure of the 2024 Annual Report

· Issued by Qinghai Spring Medicinal Resources Technology Co.,ltd. Class A via Shanghai Stock Exchange
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure of the 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis